Rare-Disease Variant Caseboards

Projection: rare-disease teams will work from a shared, living caseboard that joins regulatory variants, phenotypes, molecular evidence, and candidate experiments. Its value is not a single answer. It is a visible history of why hypotheses rose, what evidence is missing, and where clinicians, geneticists, and families still disagree.